Erythromycin estolate

依托红霉素

Report date: 2026/03/30 17:02:26

Base Information

Drug NameErythromycin estolate
Drug Alias Name红霉素丙酸酯十二烷基硫酸盐Erythromycin Propionate Lauryl SulphateEritromicino estolatas无味红霉素Erythromycini estolas +[10] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsRespiratory Tract InfectionsPelvic Inflammatory DiseaseDiphtheria +[5] 
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date1981/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesHuangshi Huangkang Pharmaceutical Co Ltd
Inactive CompaniesEli Lilly And Company
Active IndicationsBacterial Infections
Inactive IndicationsRespiratory Tract InfectionsPelvic Inflammatory DiseaseDiphtheria +[4] 

Other Information

ATC CodeD10AF02J01FA01S01AA17
Related LinksWikipediaDrugBankKEGG